MBRX icon

Moleculin Biotech (MBRX)

NASDAQ

$2.21

$0.00 (

0.00%

)

1D
5D
1M
6M
1Y
5Y
Market closed

MBRX: $2.21 / ₿ 0 BTC / 3307 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$2.21
$1.79 - $28.61
$11.79M
2.81
5.34M
$2.18 - $2.33
No

What is Moleculin Biotech (MBRX)?

Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.

The Moleculin Biotech (MBRX) stock price has been falling

The Moleculin Biotech, Inc. Common Stock (MBRX) stock price today is $2.21, reflecting a 0.00% move since the market opened. The company’s market capitalization stands at $11.79M, with a daily trading volume of shares. The previous closing price was $2.21.

Get started with Moleculin Biotech (MBRX)

Ready to get started? Follow the steps below, or read our guide on how to buy Moleculin Biotech stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy MBRX

Search for MBRX in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy MBRX.

MBRX FAQs

MBRX is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

MBRX is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Moleculin Biotech, Inc. Common Stock (MBRX) has traded between a low of $1.79 and a high of $28.61.

MBRX is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Moleculin Biotech? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
MBRX icon
MBRX

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy Moleculin Biotech in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

LICYQ icon

LICYQ

RBOTW icon

Top losers

Compare the worst-performing stocks of 
the day

SDCCQ icon
YOTAR icon

YOTAR

BBIG icon

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.